** Shares of some U.S. drugmakers fall premarket, amid a broader market sell-off, after U.S. President Donald Trump threatened steep tariffs on the sector
** The pharma sector had briefly ducked Trump's sweeping tariffs announcement on Wednesday, but some of the stocks have wiped off gains from the previous session after he said the sector was under review
** Shares of Merck MRK.N down 1.6%, Biogen BIIB.O down 1.3%, Pfizer PFE.N down 2% and Eli Lilly LLY.N down 3% before the bell
** MRK, AbbVie ABBV.N and Amgen AMGN.O climbed between 2% and 3% on Thursday
** Up to last close, LLY up 2.2% , MRK down 13.2%, BIIB down 14.5% and PFE down 8.4% YTD
(Reporting by Christy Santhosh)
((Christy.Santhosh@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。